Gilead Sciences (GILD) EV to FCF (2009 - 2026)
Gilead Sciences' (GILD) quarterly EV to FCF came in at 44.72 in Q2 2026, down 75.68% on a YoY basis from 183.89 in Q2 2025, and down 34.37% quarter-over-quarter from 68.14 in Q1 2026.
Analysis
Gilead Sciences (GILD) EV to FCF (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported EV to FCF for 18 consecutive years, with 44.72 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EV to FCF fell 75.68% year-over-year to 44.72; the trailing twelve-month figure through Jun 2026 stood at 11.86 (down 16.07% YoY), and the FY2025 full-year result was 15.29, up 50.06% from the prior year.
- EV to FCF slipped to 44.72 in Q2 2026 per GILD's latest filing, from 68.14 in the prior quarter.
- Across five years, EV to FCF topped out at 183.89 in Q2 2025 and bottomed at 23.83 in Q3 2024.
- Historically, EV to FCF has averaged 54.62 across 5 years, with a median of 44.1 in 2026.
- The sharpest annual moves came in 2025 and 2026: EV to FCF jumped 165.94% in 2025, then sank 75.68% in 2026.
- Over 5 years, EV to FCF stood at 42.18 in 2022, then increased by 13.56% to 47.9 in 2023, then slipped by 22.47% to 37.14 in 2024, then gained by 24.73% to 46.32 in 2025, then dropped by 3.45% to 44.72 in 2026.
- According to Business Quant data, EV to FCF over the past three periods registered 44.72, 68.14, and 46.32 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.72 |
| Mar 31, 2026 | 68.14 |
| Dec 31, 2025 | 46.32 |
| Sep 30, 2025 | 32.93 |
| Jun 30, 2025 | 183.89 |
| Mar 31, 2025 | 79.55 |
| Dec 31, 2024 | 37.14 |
| Sep 30, 2024 | 23.83 |
| Jun 30, 2024 | 69.15 |
| Mar 31, 2024 | 40.90 |
| Dec 31, 2023 | 47.90 |
| Sep 30, 2023 | 52.98 |
| Jun 30, 2023 | 40.64 |
| Mar 31, 2023 | 59.70 |
| Dec 31, 2022 | 42.18 |
| Sep 30, 2022 | 26.49 |
| Jun 30, 2022 | 43.29 |
| Mar 31, 2022 | 43.49 |
| Dec 31, 2021 | 27.72 |
| Sep 30, 2021 | 26.31 |